Use of Thalidomide in Patients With Arachnoiditis

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

NCT04163419 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

NCT00016458 ·Status: COMPLETED ·Phase: PHASE2

Canakinumab for Treatment of Adult-onset Still's Disease

NCT02204293 ·Status: TERMINATED ·Phase: PHASE2

Sacral Nerve Stimulation for Mild-to-Moderate or Refractory Rheumatoid Arthritis

NCT04821050 ·Status: UNKNOWN ·Phase: NA

A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy

NCT05405361 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07154524 ·Status: RECRUITING

Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.

NCT01625182 ·Status: COMPLETED ·Phase: PHASE3

Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis

NCT04620772 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies

NCT03864185 ·Status: COMPLETED ·Phase: PHASE2

Methimazole to Treat Polymyositis and Dermatomyositis

NCT00001421 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy

NCT05225675 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient

NCT07223632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

TNFα Monoclonal Antibody for Acute Spinal Cord Injury

NCT04988425 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy

NCT00278629 ·Status: COMPLETED ·Phase: PHASE2

Intravenous Immunoglobulins in Complex-regional Pain Syndrome

NCT00949065 ·Status: WITHDRAWN ·Phase: PHASE3

A Study of MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)

NCT04948554 ·Status: TERMINATED ·Phase: PHASE1

Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms

NCT00487708 ·Status: COMPLETED ·Phase: PHASE2

Early Detection of Neuropathy in ATTRv

NCT05311488 ·Status: COMPLETED

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

NCT03669588 ·Status: COMPLETED ·Phase: PHASE3

Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy

NCT04480450 ·Status: WITHDRAWN ·Phase: PHASE2

Eliglustat on Gaucher Disease Type IIIB

NCT03519646 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

NCT03772587 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

NCT02965573 ·Status: COMPLETED ·Phase: PHASE2

Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis

NCT03092154 ·Status: TERMINATED ·Phase: NA

Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT01017159 ·Status: COMPLETED ·Phase: PHASE2